CervoMed Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CervoMed Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 580% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 87% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
CervoMed Inc. made a loss over the last year. CervoMed Inc. owes $0.12 for every $1 it owns. CervoMed Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCervoMed Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.48The share price is 1.48 times CervoMed Inc.'s book value per share, lower than 68% of Healthcare companies in United States.
Market cap
$34 MThe total market value of all of CervoMed Inc.'s shares at today's price (share price × number of shares), smaller than 78% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$23 MWhat CervoMed Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.52Net worth divided by the number of shares. The share price of $2.24 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
-107.6%CervoMed Inc. lost 107.6% of its shareholders' money over the last year, lower than 73% of Healthcare companies in United States.
Owes vs Owns
0.12×CervoMed Inc. owes $0.12 for every $1 it owns (low), lower than 84% of Healthcare companies in United States.
Dividend yield
NoneCervoMed Inc. does not currently pay a dividend.
Profit growth
LossCervoMed Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CervoMed Inc.: $34 M ÷ $23 M (30 Jun 2026) = 1.5.
What is CervoMed Inc.'s return on equity?
CervoMed Inc. lost 107.6% of its shareholders' money over the last year, lower than 73% of Healthcare companies in United States.
How much does CervoMed Inc. owe compared with what it owns?
CervoMed Inc. owes $0.12 for every $1 it owns (low), lower than 84% of Healthcare companies in United States.
Does CervoMed Inc. pay a dividend?
No. CervoMed Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.